1. Home
  2. APGE vs CAAP Comparison

APGE vs CAAP Comparison

Compare APGE & CAAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

N/A

Current Price

$134.75

Market Cap

4.7B

Sector

Health Care

ML Signal

N/A

Logo Corporacion America Airports SA

CAAP

Corporacion America Airports SA

N/A

Current Price

$23.27

Market Cap

4.5B

ML Signal

N/A

Company Overview

Basic Information
Metric
APGE
CAAP
Founded
2022
1998
Country
United States
Luxembourg
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Aerospace
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.5B
IPO Year
2023
2017

Fundamental Metrics

Financial Performance
Metric
APGE
CAAP
Price
$134.75
$23.27
Analyst Decision
Strong Buy
Buy
Analyst Count
13
3
Target Price
$109.67
$26.73
AVG Volume (30 Days)
1.2M
177.1K
Earning Date
05-12-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$5.80
Revenue Next Year
N/A
$2.36
P/E Ratio
N/A
$26.35
Revenue Growth
N/A
N/A
52 Week Low
$35.39
$17.36
52 Week High
$134.88
$30.50

Technical Indicators

Market Signals
Indicator
APGE
CAAP
Relative Strength Index (RSI) 77.42 33.77
Support Level $134.03 $21.98
Resistance Level $134.88 $26.63
Average True Range (ATR) 0.20 0.91
MACD -0.75 -0.26
Stochastic Oscillator 87.65 23.89

Price Performance

Historical Comparison
APGE
CAAP

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About CAAP Corporacion America Airports SA

Corporacion America Airports SA acquires, develops, and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador, and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.

Share on Social Networks: